These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12534451)

  • 21. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin.
    Hansen L; Hansen T; Vestergaard H; Bjørbaek C; Echwald SM; Clausen JO; Chen YH; Chen MX; Cohen PT; Pedersen O
    Hum Mol Genet; 1995 Aug; 4(8):1313-20. PubMed ID: 7581368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo insulin regulation of skeletal muscle glycogen synthase in calorie-restricted and in ad libitum-fed rhesus monkeys.
    Ortmeyer HK
    J Nutr; 2001 Mar; 131(3):907S-912S. PubMed ID: 11238784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.
    Wu Y; Ouyang JP; Wu K; Wang SS; Wen CY; Xia ZY
    Br J Pharmacol; 2005 Sep; 146(2):234-43. PubMed ID: 15997237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.
    Damsbo P; Vaag A; Hother-Nielsen O; Beck-Nielsen H
    Diabetologia; 1991 Apr; 34(4):239-45. PubMed ID: 1906024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise.
    Yokoyama H; Mori K; Emoto M; Araki T; Teramura M; Mochizuki K; Tashiro T; Motozuka K; Inoue Y; Nishizawa Y
    Diabetes Obes Metab; 2008 May; 10(5):400-7. PubMed ID: 18410564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects.
    Kashyap SR; Roman LJ; Lamont J; Masters BS; Bajaj M; Suraamornkul S; Belfort R; Berria R; Kellogg DL; Liu Y; DeFronzo RA
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1100-5. PubMed ID: 15562034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
    Miyazaki Y; He H; Mandarino LJ; DeFronzo RA
    Diabetes; 2003 Aug; 52(8):1943-50. PubMed ID: 12882909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.
    Goldfine AB; Patti ME; Zuberi L; Goldstein BJ; LeBlanc R; Landaker EJ; Jiang ZY; Willsky GR; Kahn CR
    Metabolism; 2000 Mar; 49(3):400-10. PubMed ID: 10726921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
    Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
    Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
    Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR
    Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats.
    Begum N; Ragolia L
    Metabolism; 1998 Jan; 47(1):54-62. PubMed ID: 9440478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.
    Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA
    J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
    Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
    Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of skeletal muscle glucose 6-phosphate to glucose disposal rate and glycogen synthase activity in insulin-resistant and non-insulin-dependent diabetic rhesus monkeys.
    Ortmeyer HK; Bodkin NL; Hansen BC
    Diabetologia; 1994 Feb; 37(2):127-33. PubMed ID: 8163045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.
    Kim YB; Nikoulina SE; Ciaraldi TP; Henry RR; Kahn BB
    J Clin Invest; 1999 Sep; 104(6):733-41. PubMed ID: 10491408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Alford F; Vaag A; Handberg A; Beck-Nielsen H
    Metabolism; 1999 Sep; 48(9):1128-35. PubMed ID: 10484052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus.
    Vestergaard H; Lund S; Larsen FS; Bjerrum OJ; Pedersen O
    J Clin Invest; 1993 Jun; 91(6):2342-50. PubMed ID: 8514849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.